002940 Share Price | Zhejiang Anglikang Pharmaceutical Co. Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 1.80% and Operating profit at -1.58% over the last 5 years

Flat results in Mar 26

With ROE of 9.35%, it has a fair valuation with a 3.37 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 5,019 Million (Small Cap)

P/E

34.00

Industry P/E

Dividend Yield

1.00%

Debt Equity

-0.08

Return on Equity

9.35%

Price to Book

3.05

Revenue and Profits:

Net Sales:

287 Million

(Quarterly Results - Jun 2026)

Net Profit:

43 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-17.11%

6 Months

-18.65%

1 Year

-40.07%

2 Years

88.2%

3 Years

25.07%

4 Years

-33.13%

5 Years

-21.93%

Zhejiang Anglikang Pharmaceutical Co. Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.80%

EBIT Growth (5y)

-1.58%

EBIT to Interest (avg)

40.26

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.63

Tax Ratio

11.49%

Dividend Payout Ratio

40.10%

Pledged Shares

Institutional Holding

ROCE (avg)

10.78%

ROE (avg)

10.46%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.19

EV to EBIT

33.34

EV to EBITDA

24.17

EV to Capital Employed

3.38

EV to Sales

3.61

PEG Ratio

1.88

Dividend Yield

1.44%

ROCE (Latest)

10.13%

ROE (Latest)

9.35%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -24.26% vs -13.79% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -24.22% vs -25.45% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "286.90",
          "val2": "378.80",
          "chgp": "-24.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.10",
          "val2": "69.60",
          "chgp": "-22.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.80",
          "val2": "3.40",
          "chgp": "-17.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "43.50",
          "val2": "57.40",
          "chgp": "-24.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.70%",
          "val2": "132.00%",
          "chgp": "-1.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.10% vs -5.30% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.16% vs -17.04% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,415.30",
          "val2": "1,523.40",
          "chgp": "-7.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "227.70",
          "val2": "204.10",
          "chgp": "11.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.60",
          "val2": "17.10",
          "chgp": "-20.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-1.80",
          "chgp": "111.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "156.70",
          "val2": "151.90",
          "chgp": "3.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "105.80%",
          "val2": "75.90%",
          "chgp": "2.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]